SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-17-010541
Filing Date
2017-07-20
Accepted
2017-07-20 16:38:57
Documents
1
Period of Report
2017-07-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 1678
  Complete submission text file 0001179110-17-010541.txt   3202
Mailing Address CLONSHAUGH BUSINESS AND TECHNOLOGY PARK COOLOCK, DUBLIN L2 D17 E400
Business Address CLONSHAUGH BUSINESS AND TECHNOLOGY PARK COOLOCK, DUBLIN L2 D17 E400 (216) 523-5000
Allergan plc (Issuer) CIK: 0001578845 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 400 INTERPACE PARKWAY PARSIPPANY NJ 07054
Business Address
Boccuzi Joseph H (Reporting) CIK: 0001712446 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36867 | Film No.: 17974677